Phase I Study of EOS789

Status

Unknown

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222940

Enrollment

112

Registered

2015-08-18

Start date

2015-08-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

investigational material(s) Generic name etc : EOS789 INN of investigational material : Therapeutic category code : 219 Other cardiovascular agents Dosage and Administration for Investigational mater

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Japanese or Caucasian healthy male volunteers aged 20 to 44 years Body mass index (BMI) between 18.5 and 25.0 kg/m^2 for Japanese subjects and 18.5 and 30.0 kg/m^2 for Caucasian subjects at the time of screening

Exclusion criteria

Exclusion criteria: Evidence of any cardiovascular, renal, hepatic, gastrointestinal, hematologic, immunologic, nervous, endocrine, metabolic, pulmonary disorders or history of these disorders with renal, hepatic, cardiac function disorder

Design outcomes

Primary

Measure	Time frame
Safety, tolerability and pharmacokinetics Observation/examination	—

Secondary

Measure	Time frame
Pharmacodynamics Examination	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026